IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
